Secondary Interval Cytoreductive Surgery in Platinum-sensitive Recurrent Epithelial Ovarian Cancer

This study is evaluating a second surgery to remove as much remaining cancer as possible (secondary cytoreductive surgery) in women with ovarian, fallopian tube, or peritoneal cancer that has come back after initial treatment and is still responding to platinum-based chemotherapy. **You may be eligible if...** - You have confirmed epithelial ovarian, fallopian tube, or primary peritoneal carcinoma - You have received at least 3 cycles of platinum-based chemotherapy during initial treatment - It has been at least 6 months since your last platinum chemotherapy dose (platinum-sensitive recurrence) - You were not a candidate for full tumor removal upfront - You are in good general health (ECOG 0–2) with adequate organ function **You may NOT be eligible if...** - You have non-epithelial or borderline ovarian tumors - You have had another cancer in the past 5 years (with limited exceptions) - Your cancer is no longer responding to platinum chemotherapy Talk to your doctor to see if this trial is right for you.